Compare · head to head
GC Biopharma vs KT & G
KT & G ranks higher overall — 360 rank 100 vs 52.
GC Biopharma leads on Value (62 vs 50) and Quality (67 vs 56). KT & G leads on Growth (76 vs 50), Safety (90 vs 25) and Sentiment (60 vs 47).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Food, Drinks & Tobacco |
| Industry | Biotechnology | Tobacco |
| Size | Small | Large |
| ISIN | KR7006280002 | KR7033780008 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 52 | 100 |
| Value | 62 | 50 |
| Quality | 67 | 56 |
| Growth | 50 | 76 |
| Safety | 25 | 90 |
| Sentiment | 47 | 60 |
| Quality details | ||
| Profitability | 76 | 70 |
| Cash Truth | 58 | 42 |
GC Biopharma vs JW PharmaceuticalGC Biopharma vs Green CrossGC Biopharma vs HandokGC Biopharma vs Chong Kun DangAdd a third stock →
Full analyses: GC Biopharma · KT & G
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100